Cargando…

Deciphering CHFR Role in Pancreatic Ductal Adenocarcinoma

Checkpoint with forkhead-associated and ring finger domains (CHFR) has been proposed as a predictive and prognosis biomarker for different tumor types, but its role in pancreatic ductal adenocarcinoma (PDAC) remains unknown. The aim of this study was two-pronged: to review the role of CHFR in PDAC a...

Descripción completa

Detalles Bibliográficos
Autores principales:	González-Borja, Iranzu, Alors-Pérez, Emilia, Amat, Irene, Alonso, Laura, Viyuela-García, Cristina, Goñi, Saioa, Reyes, José C., Ceballos-Chávez, María, Hernández-García, Irene, Sánchez-Frías, Marina E., Santamaría, Enrique, Razquin, Socorro, Arjona-Sánchez, Álvaro, Arrazubi, Virginia, Pérez-Sanz, Jairo, Vera, Ruth, Fernández-Irigoyen, Joaquín, Castaño, Justo P., Viúdez, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8639583/ https://www.ncbi.nlm.nih.gov/pubmed/34869418 http://dx.doi.org/10.3389/fmed.2021.720128

Ejemplares similares

Cytokines and Lymphoid Populations as Potential Biomarkers in Locally and Borderline Pancreatic Adenocarcinoma
por: González-Borja, Iranzu, et al.
Publicado: (2022)

Omics Approaches in Pancreatic Adenocarcinoma
por: González-Borja, Iranzu, et al.
Publicado: (2019)

CHFR and Paclitaxel Sensitivity of Ovarian Cancer
por: Wahner Hendrickson, Andrea E., et al.
Publicado: (2021)

Dysregulated splicing factor SF3B1 unveils a dual therapeutic vulnerability to target pancreatic cancer cells and cancer stem cells with an anti-splicing drug
por: Alors-Perez, Emilia, et al.
Publicado: (2021)

Chfr and RNF8 synergistically regulate ATM activation
por: Wu, Jiaxue, et al.
Publicado: (2011)

TOPK and PTEN participate in CHFR mediated mitotic checkpoint()
por: Shinde, Swapnil R., et al.
Publicado: (2013)

CHFR is important for the first wave of ubiquitination at DNA damage sites
por: Liu, Chao, et al.
Publicado: (2013)

Silencing of CHFR Sensitizes Gastric Carcinoma to PARP Inhibitor Treatment
por: Li, Yuan, et al.
Publicado: (2019)

The hypermethylation of the CDKN2A and CHFR promoter region is a key regulatory mechanism of CDKN2A and CHFR expression in esophageal squamous cell carcinoma
por: Mei, Xinyu, et al.
Publicado: (2019)

Promoter hypermethylation of the Chfr gene in neoplastic and non-neoplastic gastric epithelia
por: Honda, T, et al.
Publicado: (2004)

Methylation of CHFR sensitizes esophageal squamous cell cancer to docetaxel and paclitaxel
por: Yun, Tianyang, et al.
Publicado: (2015)

CHFR negatively regulates SIRT1 activity upon oxidative stress
por: Kim, Myungjin, et al.
Publicado: (2016)

Upregulation of the checkpoint protein CHFR is associated with tumor suppression in pancreatic cancers
por: Zhang, Di, et al.
Publicado: (2017)

Clinicopathological significance of CHFR promoter methylation in gastric cancer: a meta-analysis
por: Ding, Yong, et al.
Publicado: (2017)

The uprise of RNA biology in neuroendocrine neoplasms: altered splicing and RNA species unveil translational opportunities
por: Blázquez-Encinas, Ricardo, et al.
Publicado: (2022)

Chfr acts with the p38 stress kinases to block entry to mitosis in mammalian cells
por: Matsusaka, Takahiro, et al.
Publicado: (2004)

Emerging evidence for CHFR as a cancer biomarker: from tumor biology to precision medicine
por: Derks, Sarah, et al.
Publicado: (2013)

Association between CHFR gene hypermethylation and gastric cancer risk: a meta-analysis
por: Shi, Hua, et al.
Publicado: (2016)

CHFR regulates chemoresistance in triple-negative breast cancer through destabilizing ZEB1
por: Luo, Hong, et al.
Publicado: (2021)

The diagnostic and prognostic value of CHFR hypermethylation in colorectal cancer, a meta-analysis and literature review
por: Sun, Zhulei, et al.
Publicado: (2017)

Association of CHFR Promoter Methylation with Treatment Outcomes of Irinotecan-Based Chemotherapy in Metastatic Colorectal Cancer
por: Cha, Yongjun, et al.
Publicado: (2018)

Ghrelin-O-Acyltransferase (GOAT) Enzyme as a Novel Potential Biomarker in Gastroenteropancreatic Neuroendocrine Tumors
por: Herrera-Martínez, Aura D., et al.
Publicado: (2018)

Dietary Intervention Modulates the Expression of Splicing Machinery in Cardiovascular Patients at High Risk of Type 2 Diabetes Development: From the CORDIOPREV Study
por: del Río-Moreno, Mercedes, et al.
Publicado: (2020)

Spliceosomal profiling identifies EIF4A3 as a novel oncogene in hepatocellular carcinoma acting through the modulation of FGFR4 splicing
por: López‐Cánovas, Juan L., et al.
Publicado: (2022)

Splicing alterations in pancreatic ductal adenocarcinoma: a new molecular landscape with translational potential
por: Alors-Pérez, Emilia, et al.
Publicado: (2023)

CHFR Promoter Hypermethylation Is Associated with Gastric Cancer and Plays a Protective Role in Gastric Cancer Process
por: Dai, Dongjun, et al.
Publicado: (2019)

Sustained expression of miR-26a promotes chromosomal instability and tumorigenesis through regulation of CHFR
por: Castellano, Leandro, et al.
Publicado: (2017)

Ubiquitin ligase CHFR mediated degradation of VE-cadherin through ubiquitylation disrupts endothelial adherens junctions
por: Tiruppathi, Chinnaswamy, et al.
Publicado: (2023)

Molecular and Clinical Implications of Somatostatin Receptor Profile and Somatostatin Analogues Treatment in Oral Cavity Squamous Cell Carcinoma
por: Sanjuan-Sanjuan, Alba, et al.
Publicado: (2021)

Small molecule inhibition of the CHFR-PARP1 interaction as novel approach to overcome intrinsic taxane resistance in cancer
por: Brodie, Seth A., et al.
Publicado: (2015)

Clinicopathological significance of CHFR methylation in non-small cell lung cancer: a systematic review and meta-analysis
por: Wang, Chen, et al.
Publicado: (2017)

Analysis of the methylation of CpG islands in the CDO1, TAC1 and CHFR genes in pancreatic ductal cancer
por: Maekawa, Hiroshi, et al.
Publicado: (2020)

CHFR promotes metastasis of human gastric carcinoma by activating AKT and ERK via NRF2- ROS axis
por: He, Feiyun, et al.
Publicado: (2023)

Prediction of Immune-Related Adverse Events Induced by Immune Checkpoint Inhibitors With a Panel of Autoantibodies: Protocol of a Multicenter, Prospective, Observational Cohort Study
por: Les, Iñigo, et al.
Publicado: (2022)

Epidermal Growth Factor Receptor (EGFR) Crosstalks in Liver Cancer
por: Berasain, Carmen, et al.
Publicado: (2011)

The checkpoint protein Chfr is a ligase that ubiquitinates Plk1 and inhibits Cdc2 at the G2 to M transition
por: Kang, Dongmin, et al.
Publicado: (2002)

The Anti-Proliferative Effects of the CHFR Depend on the Forkhead Associated Domain, but not E3 Ligase Activity Mediated by Ring Finger Domain
por: Fukuda, Tomokazu, et al.
Publicado: (2008)

The inhibition of UBC13 expression and blockage of the DNMT1-CHFR-Aurora A pathway contribute to paclitaxel resistance in ovarian cancer
por: Zhang, Xu, et al.
Publicado: (2018)

CHFR promotes the migration of human gastric cancer cells by inducing epithelial-to-mesenchymal transition in a HDAC1-dependent manner
por: Yang, Shangwen, et al.
Publicado: (2019)

Flavin adenine dinucleotide-capped gold nanoclusters: biocompatible photo-emissive nanomaterial and reservoir of lumichrome
por: Pérez-Herráez, Irene, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7teil1onfji1olu3gdeb3h4k5g